Humaflox-M Oral Suspension Mango is a combination antibiotic and antiflatulent formulation containing Ofloxacin (50mg/5ml), Metronidazole (120mg/5ml), and Simethicone (10mg/5ml). Ofloxacin, a fluoroquinolone antibiotic, exhibits broad-spectrum bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, effectively treating various bacterial infections. Metronidazole, an antiprotozoal and antibacterial agent, acts by disrupting DNA synthesis in anaerobic bacteria and protozoa, making it effective against anaerobic infections and certain protozoal diseases. Simethicone serves as an anti-foaming agent that reduces bloating and discomfort caused by excess gas in the gastrointestinal tract by coalescing gas bubbles, facilitating their expulsion. Humaflox-M Oral Suspension is indicated for the treatment of mixed infections involving susceptible aerobic and anaerobic bacteria, including gastrointestinal infections, intra-abdominal infections, and certain protozoal infections accompanied by symptoms of flatulence and abdominal discomfort. The mango-flavored suspension enhances palatability, improving patient compliance, especially in pediatric and geriatric populations. Dosage and duration should be determined by a healthcare professional based on the severity and type of infection. Caution is advised in patients with hypersensitivity to fluoroquinolones, nitroimidazoles, or simethicone, and it is contraindicated during pregnancy and lactation unless clearly necessary. Adverse effects may include gastrointestinal disturbances, headache, dizziness, and hypersensitivity reactions.